Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Down 2.9% – Here’s Why

Bayer Aktiengesellschaft (ETR:BAYN) shares traded down 2.9% during mid-day trading on Thursday . The stock traded as low as €47.53 and last traded at €47.71. Approximately 2,371,699 shares changed hands during mid-day trading, The stock had previously closed at €49.12.

Bayer Aktiengesellschaft Price Performance

The company has a debt-to-equity ratio of 134.81, a quick ratio of 0.72 and a current ratio of 1.06. The company has a market cap of $48.17 billion, a price-to-earnings ratio of -54.74, a PEG ratio of 36.39 and a beta of 0.83. The business has a fifty day moving average price of €40.88 and a 200 day moving average price of €40.89.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.